文献速递前列腺癌

医院层面差异导致前列腺癌诊疗质量参差不齐

Hospital-level Effects Contribute to Variations in Prostate Cancer Quality of Care.
PubMed 文献 · Eur Urol Oncol · 2020-09-13

该研究基于1245家医院的真实世界数据,采用间接标准化调整病例组合后,对前列腺癌质量指标进行基准评价,并构建前列腺癌质量评分(PC-QS)。结果显示调整病例组合后,2%–37%的医院在特定质量指标上显著低于全国平均水平,且PC-QS较高的医院患者量更大、多为学术附属且总体死亡率更低。

要点

  • 调整病例组合后,2%–37%的医院在特定质量指标上显著低于全国平均水平。
  • PC-QS较高的医院患者量更大、多为学术附属且总体死亡率更低。
  • PC-QS是一种新型、经过验证的质量基准工具。

核心结论

  • 调整病例组合后,前列腺癌诊疗质量在医院层面存在广泛差异。
  • PC-QS可作为新型、经过验证的质量基准工具。

研究设计与样本

  • 基于1245家医院的真实世界数据,采用间接标准化调整病例组合,对既往报道的疾病特异性专家定义质量指标进行医院层面基准评价。
  • 构建前列腺癌质量评分(PC-QS),并分析其与医院规模、学术状态、位置及患者全因死亡率的关系。

主要发现

  • 调整病例组合后,1245家医院中2%–37%的医院在特定质量指标上显著低于全国平均水平。
  • PC-QS较高的医院患者量更大、更常见学术附属且总体死亡率更低。

临床怎么用

  • 可利用PC-QS对医院前列腺癌诊疗质量进行基准评价和比较。
  • 质量改进应关注医院层面差异,而非仅归因于病例组合。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A paucity of real-world data exists highlighting whether variations in prostate cancer quality of care occur at a hospital level, independent of differences in case mix. To overcome this knowledge gap, we benchmarked hospital-level quality (n = 1245 hospitals) across a broad multidisciplinary panel of previously reported disease-specific, expert-defined quality indicators (QIs), adjusting for differences in patient case mix by indirect standardization. A composite measure of prostate cancer quality-the prostate cancer quality score (PC-QS)-was derived, and associations between PC-QS and hospital volume, academic status, and location as well as patient all-cause mortality were determined. After adjusting for the case mix, of the total of 1245 hospitals evaluated, 2-37% were identified as those performing significantly below the national average for a given QI. Hospitals with a higher PC-QS displayed larger patient volumes, were more commonly academic affiliated, and had lower overall mortality. Collectively, our data-driven benchmarking analysis reveals that widespread hospital-level variations exist in prostate cancer quality of care after adjusting for differences in case mix, with the PC-QS serving as a novel, validated, quality benchmarking tool. PATIENT SUMMARY: Our statistical benchmarking method shows that the quality of prostate cancer care varies between hospitals, after accounting for differences in patient characteristics. The prostate cancer quality score is a novel, validated, quality benchmarking tool.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Lawson KA, Daignault K, Abouassaly R, et al. Hospital-level Effects Contribute to Variations in Prostate Cancer Quality of Care. Eur Urol Oncol. 2020. PMID: 32938571. doi:10.1016/j.euo.2020.08.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。